Health News Roundup: UNICEF on Mpox, Bird Flu in Missouri, and US Drug Price Negotiation Challenge

This summary covers current health news including UNICEF's fight against mpox stigma in Burundi, bird flu symptoms developed by a Missouri health worker, and the revival of a US drug price negotiation program challenge by an appeals court. Key developments and implications in the health sector are highlighted.


Devdiscourse News Desk | Updated: 23-09-2024 02:27 IST | Created: 23-09-2024 02:27 IST
Health News Roundup: UNICEF on Mpox, Bird Flu in Missouri, and US Drug Price Negotiation Challenge
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.

The United Nations' Children's Fund (UNICEF) stresses the importance of tackling the stigma surrounding mpox to swiftly end the outbreak in Burundi. The World Health Organization declared an emergency in August due to a new variant causing pus-filled blisters.

A Missouri healthcare worker developed mild respiratory symptoms after contact with a bird flu patient, according to US officials. This is the third reported case of symptoms among those who had contact with the hospitalized bird flu patient, all of whom have recovered.

In legal news, a U.S. appeals court has revived a significant case challenging Medicare's new drug price negotiation program. Healthcare and pharmaceutical industry groups argue against the law requiring drug companies to negotiate prices with Medicare, affecting 66 million people. The New Orleans-based court ruled that a Texas judge incorrectly dismissed the case without considering its merits.

(With inputs from agencies.)

Give Feedback